Patent - Abbreviated New Drug Application Cases
Cases 151 - 160 of 2,129
Novartis Pharmaceuticals Corporation et al v. Novugen Oncology Sdn. Bhd. et al
as 1:2023cv01449
Plaintiff: Novartis Pharmaceuticals Corporation, Novartis Pharma AG and Japan Tobacco Inc.
Defendant: Novugen Oncology Sdn. Bhd., Novugen Pharma (USA) LLC and Makro Technologies, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
PURDUE PHARMA L.P. et al v ELITE LABORATORIES INC, et al.
as 1:2023cv22221
Plaintiff: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P. and RHODES TECHNOLOGIES
Defendant: ELITE LABORATORIES, INC. and ELITE PHARMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Astrazeneca AB et al v. ScieGen Pharmaceuticals, Inc.
as 1:2023cv01457
Plaintiff: Astrazeneca AB and AstraZeneca Pharmaceuticals LP
Defendant: ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
ENDO PAR INNOVATION COMPANY, LLC et al v. DEVA HOLDING A.S.
as 1:2023cv21684
Plaintiff: ENDO PAR INNOVATION COMPANY, LLC, PAR PHARMACEUTICAL, INC. and PAR STERILE PRODUCTS, LLC
Defendant: DEVA HOLDING A.S.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Harmony Biosciences, LLC et al v. Lupin Limited et al
as 1:2023cv01286
Plaintiff: Harmony Biosciences, LLC, Bioprojet Societe Civile de Recherche and Bioprojet Pharma SAS
Defendant: Lupin Limited, Lupin Pharmaceuticals, Inc., Novugen Pharma Sdn. Bhd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. AMNEAL PHARMACEUTICALS OF NEW YORK, LLC et al
as 2:2023cv20964
Plaintiff: TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., NORTON (WATERFORD) LTD. and TEVA PHARMACEUTICALS USA, INC.
Defendant: AMNEAL PHARMACEUTICALS OF NEW YORK, LLC, AMNEAL IRELAND LIMITED, AMNEAL PHARMACEUTICALS LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Meitheal Pharmaceuticals, Inc. et al
as 1:2023cv01195
Plaintiff: Novo Nordisk Inc. and Novo Nordisk A/S
Defendant: Meitheal Pharmaceuticals, Inc. and Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ZS Pharma, Inc. et al. v. Lupin Limited et al.
as 1:2023cv01189
Plaintiff: ZS Pharma, Inc. and AstraZeneca Pharmaceuticals LP
Defendant: Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Cipla Ltd. et al
as 1:2023cv01196
Plaintiff: Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant: Cipla Ltd., Cipla USA Inc. and Invagen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ZS Pharma, Inc. et al v. Ascent Pharmaceuticals Inc. et al
as 1:2023cv01188
Plaintiff: ZS Pharma, Inc. and AstraZeneca Pharmaceuticals LP
Defendant: Ascent Pharmaceuticals Inc. and Hetero Drugs Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?